Scott David Solomon
Impact in
- Cardiology and Cardiovascular Medicine top 0.01%
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Cardiomyopathy and Myosin Studies
- Cardiac Valve Diseases and Treatments
- Nephrology top 0.05%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Heart Failure Treatment and Management 641
- Cardiovascular Function and Risk Factors 104
- Cardiac pacing and defibrillation studies 68
- Cardiomyopathy and Myosin Studies 52
- Nephrology 38
- Chronic Kidney Disease and Diabetes 34
- Co-authors
- John J.V. McMurray (251 shared papers)Marc Alan Pfeffer (251 shared papers)Brian Lee Claggett (251 shared papers)Jean Lucien Rouleau (227 shared papers)Karl B Swedberg (167 shared papers)Akshay Suvas Desai (251 shared papers)Michael R. Zile (199 shared papers)Milton Packer (180 shared papers)
- Journals
- European Journal of Heart Failure (226 papers)Journal of the American College of Cardiology (218 papers)JACC Heart Failure (131 papers)Circulation (128 papers)European Heart Journal (127 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Scott David Solomon
1.5k papers receiving 142.9k citations
Scott David Solomon's Hit Papers
Peers
Comparison fields: 5 of 164
- Cardiology and Cardiovascular Medicine 72.1k
- Nephrology 4.7k
- Endocrinology, Diabetes and Metabolism 7.1k
- Internal Medicine 912
- Critical Care and Intensive Care Medicine 1.0k
Countries citing papers authored by Scott David Solomon
This map shows the geographic impact of Scott David Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott David Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott David Solomon more than expected).
Fields of papers citing papers by Scott David Solomon
This network shows the impact of papers produced by Scott David Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott David Solomon. The network helps show where Scott David Solomon may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott David Solomon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.7k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology Hit paper breakdown → | 2005 | 9789 |
| 2 | Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography Hit paper breakdown → | 2010 | 5755 |
| 3 | Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction Hit paper breakdown → | 2019 | 5268 |
| 4 | Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure Hit paper breakdown → | 2014 | 5247 |
| 5 | Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis Hit paper breakdown → | 2018 | 2472 |
| 6 | Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events Hit paper breakdown → | 2009 | 2421 |
| 7 | Spironolactone for Heart Failure with Preserved Ejection Fraction Hit paper breakdown → | 2014 | 2201 |
| 8 | Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome Hit paper breakdown → | 2015 | 1959 |
| 9 | Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction Hit paper breakdown → | 2022 | 1958 |
| 10 | Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both Hit paper breakdown → | 2003 | 1946 |
| 11 | Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Hit paper breakdown → | 2019 | 1863 |
| 12 | Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention Hit paper breakdown → | 2005 | 1722 |
| 13 | A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease Hit paper breakdown → | 2009 | 1662 |
| 14 | Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 Hit paper breakdown → | 2020 | 1640 |
| 15 | Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction Hit paper breakdown → | 2004 | 1623 |
| 16 | Potential Effects of Coronaviruses on the Cardiovascular System Hit paper breakdown → | 2020 | 1399 |
| 17 | Strategies for Multivessel Revascularization in Patients with Diabetes Hit paper breakdown → | 2012 | 1382 |
| 18 | How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Hit paper breakdown → | 2019 | 1354 |
| 19 | Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis Hit paper breakdown → | 2018 | 1174 |
| 20 | Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes Hit paper breakdown → | 2012 | 1070 |
About Scott David Solomon
Scott David Solomon is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology, Endocrinology, Diabetes and Metabolism, Epidemiology and Hematology, having authored 1.7k papers that have together received 149.4k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (641 papers), Cardiovascular Function and Risk Factors (104 papers), Cardiac pacing and defibrillation studies (68 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (60 papers), Cardiomyopathy and Myosin Studies (52 papers), Influenza Virus Research Studies (42 papers), Chronic Kidney Disease and Diabetes (34 papers) and Erythropoietin and Anemia Treatment (29 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (72.1k citations), Nephrology (4.7k citations), Endocrinology, Diabetes and Metabolism (7.1k citations), Internal Medicine (912 citations) and Critical Care and Intensive Care Medicine (1.0k citations). Scott David Solomon has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include John J.V. McMurray, Marc Alan Pfeffer, Brian Lee Claggett, Jean Lucien Rouleau, Karl B Swedberg, Akshay Suvas Desai, Michael R. Zile, Milton Packer, Amil M. Shah and Martin P. Lefkowitz. Their work appears in journals such as European Journal of Heart Failure, Journal of the American College of Cardiology, JACC Heart Failure, Circulation and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.